Shine, MURR sign isotope production deal

2021-06-10

Shine Medical Technologies and the University of Missouri Research Reactor signed an agreement covering the manufacture of ytterbium-176, the precursor isotope to lutetium-177, a radioisotope used for drug applications. Under the deal, ytterbium-176 will undergo irradiation at the MURR reactor.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.